Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002027058 | SCV002308651 | uncertain significance | Insulin-dependent diabetes mellitus secretory diarrhea syndrome | 2021-09-21 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt FOXP3 protein function. This variant has not been reported in the literature in individuals affected with FOXP3-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces alanine with threonine at codon 113 of the FOXP3 protein (p.Ala113Thr). The alanine residue is weakly conserved and there is a small physicochemical difference between alanine and threonine. |
Fulgent Genetics, |
RCV002027058 | SCV002816136 | uncertain significance | Insulin-dependent diabetes mellitus secretory diarrhea syndrome | 2021-12-15 | criteria provided, single submitter | clinical testing |